Valuation: Repligen Corporation

Market Cap 10.1B 8.99B 8.33B 7.55B 14.18B 956B 14.42B 99.93B 39.26B 500B 37.87B 37.08B 1,597B P/E 2026 *
258x
P/E 2027 * 106x
Enterprise Value 10.07B 8.96B 8.3B 7.53B 14.14B 954B 14.38B 99.65B 39.15B 499B 37.76B 36.98B 1,592B EV / Sales 2026 *
12x
EV / Sales 2027 * 9.2x
Free-Float
94.95%
Yield 2026 *
-
Yield 2027 * -
1 day+1.39%
1 week+1.97%
Current month-6.94%
1 month+1.12%
3 months+22.95%
6 months+35.53%
Current year+9.17%
1 week 172.39
Extreme 172.39
186
1 month 157.44
Extreme 157.4355
198.87
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
306.98
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Director/Board Member 61 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
10/6/26 Free

Executive/Senior Manager

1,375 0.0024%
10/5/26 Sell

Chief Executive Officer

-13,939 0.0247%
10/2/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%+1.97%+15.75%+22.55% 9.96B
-1.55%-0.16%-20.89%+5.86% 180B
+2.00%+1.74%-1.34%+30.17% 114B
+2.17%+7.73%-20.15%+14.57% 114B
-1.02%+2.87%-52.05%-7.70% 78.39B
+0.96%+3.99%+4.85%+81.86% 64.88B
+4.12%+6.34%+17.84%+86.28% 54.02B
+1.60%+3.43%+1.47%-25.07% 51.96B
+0.38%+7.23%-13.29%+30.66% 43.79B
-0.28%+0.80%+25.30%-0.27% 32.45B
Average +0.96%+3.34%-4.25%+23.89% 74.33B
Weighted average by Cap. +0.67%+3.08%-11.50%+21.21%

Financials

2026 *2027 *
Net sales 836M 744M 690M 625M 1.17B 79.22B 1.19B 8.28B 3.25B 41.46B 3.14B 3.07B 132B 1.08B 961M 891M 807M 1.52B 102B 1.54B 10.69B 4.2B 53.54B 4.05B 3.97B 171B
Net income 39.9M 35.52M 32.92M 29.83M 56.06M 3.78B 57M 395M 155M 1.98B 150M 147M 6.31B 108M 96.1M 89.06M 80.7M 152M 10.23B 154M 1.07B 420M 5.35B 405M 397M 17.07B
Net Debt -28.18M -25.09M -23.25M -21.07M -39.6M -2.67B -40.26M -279M -110M -1.4B -106M -104M -4.46B -157M -140M -129M -117M -220M -14.86B -224M -1.55B -610M -7.78B -588M -576M -24.81B
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-10-20 $178.88 +1.39% 877,747
26-10-19 $176.43 +0.58% 769,102
26-10-16 $175.42 -4.75% 1,213,319
26-10-15 $184.17 +3.35% 1,043,052
26-10-14 $178.20 +1.58% 1,216,922
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
178.88USD
Average target price
199.70USD
Spread / Average Target
+11.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Repligen Corporation
  1. Stock Market
  2. Stocks
  3. RGEN Stock